Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 1101 to 1125 of 1921 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
1269 Increase, COX-2 expression
1 Molecular Feb 9, 2017 Mar 20, 2018 21: Aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2
1268 Decrease, Excitatory postsynaptic potential
1 Tissue Feb 9, 2017 May 24, 2018 None
1267 Decrease, Ecdysis motor program activity
1 Tissue Feb 9, 2017 Sep 29, 2025
1266 Decrease, Circulating crustacean cardioactive peptide
1 Tissue Feb 9, 2017 May 24, 2018
1265 Decrease, Fushi tarazu factor-1 gene expression
1 Molecular Feb 9, 2017 Sep 26, 2025 4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
1264 Increase, Nuclear receptor E75b gene expression
1 Molecular Feb 9, 2017 May 24, 2018 4: Ecdysone receptor agonism leading to mortality via suppression of Ftz-f1
1263 Necrosis
1 Tissue Feb 7, 2017 Feb 7, 2017
1262 Apoptosis
1 Cellular Feb 7, 2017 May 31, 2025
1260 Direct mitochondrial inhibition
1 Molecular Feb 7, 2017 Sep 16, 2017 205: AOP from chemical insult to cell death
1259 narcosis
1 Cellular Feb 7, 2017 Sep 16, 2017 205: AOP from chemical insult to cell death
1258 Decompartmentalization
1 Cellular Feb 7, 2017 Sep 16, 2017 205: AOP from chemical insult to cell death
1257 Induced parturition
0 Individual Jan 13, 2017 Jan 13, 2017
1256 increased mantel display
0 Organ Jan 13, 2017 Jan 13, 2017
1255 induced spawning
1 Individual Jan 13, 2017 Jan 13, 2017 195: 5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase
1254 Infant leukaemia
0 Individual Dec 16, 2016 Aug 1, 2022 202: Inhibitor binding to topoisomerase II leading to infant leukaemia
1253 MLL chromosomal translocation
1 Cellular Dec 16, 2016 Aug 1, 2022 202: Inhibitor binding to topoisomerase II leading to infant leukaemia
1252 Binding to (interferes with) topoisomerase II enzyme
1 Molecular Dec 16, 2016 Aug 1, 2022 202: Inhibitor binding to topoisomerase II leading to infant leukaemia
1251 Chronic, Mucus hypersecretion
1 Tissue Nov 29, 2016 Aug 25, 2021 None
1250 Decrease, Lung function
1 Individual Nov 29, 2016 Sep 8, 2021
1248 EGFR , Activation
0 Nov 29, 2016 Nov 29, 2016 None
1247 EGFR , PPAR-alpha activation
0 Nov 29, 2016 Nov 29, 2016 None
1246 Lung function, Decrease
0 Nov 29, 2016 Nov 29, 2016 None
1245 Mucus , Hypersecretion
0 Nov 29, 2016 Nov 29, 2016 None
1244 Mucus hypersecretion,
0 Nov 29, 2016 Nov 29, 2016 None
1243 Altered, Ca2+-calmodulin activated signal transduction
3 Cellular Nov 29, 2016 Jun 7, 2018